Gut Microbiome and Human Health: Exploring How the Probiotic Genus Modulate Immune Responses
Overview
Authors
Affiliations
The highest density of microbes resides in human gastrointestinal tract, known as "Gut microbiome". Of note, the members of the genus that belong to phyla Firmicutes are the most important probiotic bacteria of the gut microbiome. These gut-residing species not only communicate with each other but also with the gut epithelial lining to balance the gut barrier integrity, mucosal barrier defence and ameliorate the host immune responses. The human body suffers from several inflammatory diseases affecting the gut, lungs, heart, bone or neural tissues. Mounting evidence supports the significant role of spp. and their components (such as metabolites, peptidoglycans, and/or surface proteins) in modulatingimmune responses, primarily through exchange of immunological signals between gastrointestinal tract and distant organs. This bidirectional crosstalk which is mediated by spp. promotes anti-inflammatory response, thereby supporting the improvement of symptoms pertaining to asthma, chronic obstructive pulmonary disease (COPD), neuroinflammatory diseases (such as multiple sclerosis, alzheimer's disease, parkinson's disease), cardiovascular diseases, inflammatory bowel disease (IBD) and chronic infections in patients. The metabolic disorders, obesity and diabetes are characterized by a low-grade inflammation. Genus alleviates metabolic disorders by regulating the oxidative stress response and inflammatory pathways. Osteoporosis is also associated with bone inflammation and resorption. The spp. and their metabolites act as powerful immune cell controllers and exhibit a regulatory role in bone resorption and formation, supporting bone health. Thus, this review demonstrated the mechanisms and summarized the evidence of the benefit of spp. in alleviating inflammatory diseases pertaining to different organs from animal and clinical trials. The present narrative review explores in detail the complex interactions between the gut-dwelling spp. and the immune components in distant organs to promote host's health.
Abbas Z, Tong Y, Zhang J, Sammad A, Wang J, Ahmad B Front Immunol. 2025; 16:1536694.
PMID: 40040706 PMC: 11876837. DOI: 10.3389/fimmu.2025.1536694.
Izhar M, Nawaz M, Yaqub T, Avais M BMC Microbiol. 2025; 25(1):109.
PMID: 40025414 PMC: 11871703. DOI: 10.1186/s12866-025-03832-9.
Crosstalk between gut microbiotas and fatty acid metabolism in colorectal cancer.
Zhang H, Tian Y, Xu C, Chen M, Xiang Z, Gu L Cell Death Discov. 2025; 11(1):78.
PMID: 40011436 PMC: 11865559. DOI: 10.1038/s41420-025-02364-5.
Molecular pathways: the quest for effective MAO-B inhibitors in neurodegenerative therapy.
Oyovwi M, Udi O, Atere A, Joseph G, Ogbutor U Mol Biol Rep. 2025; 52(1):240.
PMID: 39961877 DOI: 10.1007/s11033-025-10349-x.
Chen J, Malhi K, Li X, Xu X, Kang J, Zhao B Anim Nutr. 2025; 20:95-109.
PMID: 39949730 PMC: 11821399. DOI: 10.1016/j.aninu.2024.09.003.